GFH312 / GenFleet Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GFH312 / GenFleet Therap
NCT04676711: A Study of GFH312 in Healthy Subjects

Completed
1
76
RoW
GFH312, Placebo
GenFleet Therapeutics (Australia) Pty Ltd.
Toxicity, Healthy
05/22
10/22
NCT05991362: A Phase I Study of GFH312 in Healthy Chinese Subjects

Completed
1
26
RoW
GFH312 100 mg, GFH312, GFH312 200 mg, GFH312 120mg, Placebo
Zhejiang Genfleet Therapeutics Co., Ltd.
Healthy Volunteer
02/23
05/23

Download Options